Reza Zadno - Oct 30, 2024 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
President, CEO, Director
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Reza Zadno, Ph.D.
Stock symbol
PRCT
Transactions as of
Oct 30, 2024
Transactions value $
-$24,989,376
Form type
4
Date filed
10/31/2024, 05:07 PM
Previous filing
Aug 23, 2024
Next filing
Nov 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Options Exercise $1.26M +288K +111.61% $4.37 547K Oct 30, 2024 Direct
transaction PRCT Common Stock Sale -$26.2M -288K -52.74% $91.00 258K Oct 30, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Stock Option (Right to Buy) Options Exercise $0 -288K -23.08% $0.00 961K Oct 30, 2024 Common Stock 288K $4.37 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold on October 30, 2024, pursuant to the underwriters exercise of an option to purchase shares as detailed in the prospectus supplement filed with the SEC, dated October 29, 2024, pursuant to Rule 424(b)(5) and Registration No. 333-273569.
F2 The Stock option was granted on February 20, 2020, and vested over a four year period.